Citadel Advisors’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6771 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6742 |
|
|
2023
Q1 | – | Sell |
-17,471
| Closed | -$9.26K | – | 6844 |
|
|
2022
Q4 | $9.26K | Sell |
17,471
-102,364
| -85% | -$54.3K | ﹤0.01% | 5696 |
|
|
2022
Q3 | $87K | Buy |
+119,835
| New | +$87K | ﹤0.01% | 5157 |
|
|
2022
Q2 | – | Sell |
-41,665
| Closed | -$86K | – | 7232 |
|
|
2022
Q1 | $86K | Sell |
41,665
-89,531
| -68% | -$185K | ﹤0.01% | 5721 |
|
|
2021
Q4 | $378K | Buy |
131,196
+53,353
| +69% | +$154K | ﹤0.01% | 4886 |
|
|
2021
Q3 | $330K | Sell |
77,843
-5,639
| -7% | -$23.9K | ﹤0.01% | 4944 |
|
|
2021
Q2 | $442K | Sell |
83,482
-128,388
| -61% | -$680K | ﹤0.01% | 4835 |
|
|
2021
Q1 | $985K | Buy |
211,870
+179,654
| +558% | +$835K | ﹤0.01% | 3945 |
|
|
2020
Q4 | $106K | Buy |
32,216
+3,534
| +12% | +$11.6K | ﹤0.01% | 4678 |
|
|
2020
Q3 | $95K | Buy |
28,682
+18,109
| +171% | +$60K | ﹤0.01% | 4264 |
|
|
2020
Q2 | $36K | Sell |
10,573
-5,893
| -36% | -$20.1K | ﹤0.01% | 4429 |
|
|
2020
Q1 | $63K | Buy |
16,466
+6,395
| +63% | +$24.5K | ﹤0.01% | 4498 |
|
|
2019
Q4 | $61K | Buy |
+10,071
| New | +$61K | ﹤0.01% | 4359 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 5265 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 5230 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5175 |
|
|
2018
Q4 | – | Sell |
-24,278
| Closed | -$198K | – | 5065 |
|
|
2018
Q3 | $198K | Buy |
+24,278
| New | +$198K | ﹤0.01% | 3753 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 4693 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 4533 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 4382 |
|
|
2017
Q3 | – | Sell |
-458,331
| Closed | -$7.78M | – | 4242 |
|
|
2017
Q2 | $7.78M | Buy |
458,331
+121,704
| +36% | +$2.07M | 0.01% | 977 |
|
|
2017
Q1 | $6.77M | Buy |
+336,627
| New | +$6.77M | 0.01% | 1068 |
|
|
2016
Q4 | – | Sell |
-16,677
| Closed | -$218K | – | 4237 |
|
|
2016
Q3 | $218K | Buy |
+16,677
| New | +$218K | ﹤0.01% | 3021 |
|